
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with ROI from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/roi/topic/2095/</link>
        <description>Articles tagged with ROI from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Pfizer speeds mobile site development with &quot;container&quot;</title>
          <description>Pfizer launched ten mobile sites in four months last year by tackling tough problems early and building a template for all its brands.</description>
          <link>http://www.mmm-online.com/pfizer-speeds-mobile-site-development-with-container/article/282066/</link>
          <pubDate>Wed, 27 Feb 2013 15:00:37 GMT</pubDate>
          <itunes:summary>Pfizer launched ten mobile sites in four months last year by tackling tough problems early and building a template for all its brands.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Study: Pharma getting more drugs approved, but less money for them</title>
          <description>Researchers said the industry closed 2012 with a mixed bag of results. The upside: more approvals than last year. The downside: projected sales for these new drugs is less.</description>
          <link>http://www.mmm-online.com/study-pharma-getting-more-drugs-approved-but-less-money-for-them/article/272925/</link>
          <pubDate>Mon, 17 Dec 2012 17:31:05 GMT</pubDate>
          <itunes:summary>Researchers said the industry closed 2012 with a mixed bag of results. The upside: more approvals than last year. The downside: projected sales for these new drugs is less.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>GSK signed the most in-license drug deals in &apos;08-&apos;09</title>
          <description>Of the top 10 pharma companies worldwide, GlaxoSmithKline looked beyond its own pipeline for new drugs most often, signing 67 in-licensing agreements in just two years, according to a Datamonitor analysis.</description>
          <link>http://www.mmm-online.com/gsk-signed-the-most-in-license-drug-deals-in-08-09/article/168387/</link>
          <pubDate>Tue, 20 Apr 2010 18:27:24 GMT</pubDate>
          <itunes:summary>Of the top 10 pharma companies worldwide, GlaxoSmithKline looked beyond its own pipeline for new drugs most often, signing 67 in-licensing agreements in just two years, according to a Datamonitor analysis.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Making Marketing Dollars Count: Made to Measure</title>
          <description>In an age of accountability, where every dollar counts, Deborah Dick-Rath talks to industry insiders about how they can make a measurable difference in their marketing mix</description>
          <link>http://www.mmm-online.com/making-marketing-dollars-count-made-to-measure/article/140897/</link>
          <pubDate>Wed, 15 Jul 2009 15:42:00 GMT</pubDate>
          <itunes:summary>In an age of accountability, where every dollar counts, Deborah Dick-Rath talks to industry insiders about how they can make a measurable difference in their marketing mix</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  